🇺🇸 NovoCure LtdNVCR

Investor Event Form 8-K 01-10-2026 09:00:29 EDT

Subject: 8-K Items 7.01, 9.01

Overview: Japan’s Ministry of Health, Labour and Welfare approved Optune Pax for treating unresectable locally advanced pancreatic cancer in adult patients on October 1, 2026.

Source: SEC EDGAR · Original filing

Open document in a new tab

Get filings like this in Telegram the moment they are published — for the companies you follow.

Start 30-day trial About Finterest